You are here:Home-Chemical Inhibitors & Agonists-Membrane Transporter/Ion Channel-Calcium Channel -NNC 55-0396
NNC 55-0396

Chemical Structure : NNC 55-0396

CAS No.: 357400-13-6

NNC 55-0396 (NNC 55-0396 dihydrochloride)

Catalog No.: PC-45854Not For Human Use, Lab Use Only.

NNC 55-0396 is a potent and selective T-type calcium channel antagonist that blocks recombinant alpha(1)G T-type channels in human embryonic kidney 293 cellswith IC50 of 7 uM.

Packing Price Stock Quantity
5 mg $128 In stock
10 mg $188 In stock
25 mg $298 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

NNC 55-0396 is a potent and selective T-type calcium channel antagonist that blocks recombinant alpha(1)G T-type channels in human embryonic kidney 293 cellswith IC50 of 7 uM.
NNC 55-0396 has no detectable effect on high-voltage-activated channels in INS-1 cells.
NNC 55-0396 inhibits MCF-7 (ERalpha+) cellular proliferation, inhibits tumor-induced angiogenesis in vitro and in vivo by suppressing HIF-1α stability.
NNC 55-0396 significantly suppresses glioblastoma tumor growth in a xenograft model.
NNC 55-0396 is a small molecule inhibitor of the PEX3-PEX19 interaction, effectively disrupts PEX3-PEX19 interaction at 4 μM.
NNC 55-0396 shows anti-tumoral effect, which is dependent on peroxisomal functions, but not on T-type calcium channels (TTCCs).
NNC 55-0396 shows anti-tumor response with MAPK-targeted therapy in melanoma.
 

Physicochemical Properties

M.Wt 564.5619
Formula C30H40Cl2FN3O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO

Chemical Name/SMILES

Cyclopropanecarboxylic acid, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, hydrochloride (1:2)

References

1. Huang L, et al. J Pharmacol Exp Ther. 2004 Apr;309(1):193-9.
2. Taylor JT, et al. Cancer Lett. 2008 Aug 18;267(1):116-24.
3. Kim KH, et al. J Mol Med (Berl). 2015 May;93(5):499-509.
4. Fan Huang, et al. J Clin Invest. 2023 Aug 24;e166644.
 

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: